We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.19%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.12B
AUM Growth
+$146M
Cap. Flow
-$6.04M
Cap. Flow %
-0.54%
Top 10 Hldgs %
16.93%
Holding
462
New
136
Increased
57
Reduced
41
Closed
111

Sector Composition

Rank Sector Weight
1 Financials 29.94%
2 Healthcare 10.97%
3 Technology 7.15%
4 Communication Services 3.95%
5 Industrials 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSTH
1
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$34.1M 3.05%
1,729,100
-632,900
-27% -$12.8M
PSTH
2
PUT
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$21.6M 1.93%
1,094,600
-653,900
-37% -$13.3M
KDMN
3
DELISTED
Kadmon Holdings, Inc.
KDMN
$20.8M 1.86%
2,383,543
+810,000
+51% +$4.61M
COHR
4
DELISTED
Coherent Inc
COHR
$18.6M 1.67%
74,493
SJR
5
DELISTED
Shaw Communications Inc.
SJR
$18.5M 1.66%
637,651
MX icon
6
Magnachip Semiconductor
MX
$128M
$17.5M 1.57%
986,430
-5,800
-0.6% -$116K
TVTX icon
7
Travere Therapeutics
TVTX
$5.33B
$15.8M 1.42%
652,372
+357,335
+121% +$6.57M
CHNG
8
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$14.7M 1.32%
703,519
VAL icon
9
Valaris
VAL
$5.51B
$14.6M 1.31%
419,899
BIIB icon
10
Biogen
BIIB
$29.9B
$13M 1.16%
+45,872
New +$15M
CIG icon
11
CEMIG Preferred Shares
CIG
$6.09B
$12.4M 1.11%
8,300,579
+422,500
+5% +$594K
XLNX
12
DELISTED
Xilinx Inc
XLNX
$11.8M 1.05%
78,060
CCXI
13
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
$11.7M 1.05%
+686,300
New +$10.7M
DELL icon
14
Dell
DELL
$283B
$11.6M 1.04%
220,437
INFO
15
DELISTED
IHS Markit Ltd. Common Shares
INFO
$10.4M 0.93%
+89,455
New +$10.6M
JXN icon
16
Jackson Financial
JXN
$8.32B
$9.91M 0.89%
+381,100
New +$10.4M
IMVT icon
17
CALL
Immunovant
IMVT
$8.09B
$9.91M 0.89%
1,139,900
+130,400
+13% +$1.18M
ESSCW
18
DELISTED
East Stone Acquisition Corporation Warrant
ESSCW
$9.79M 0.88%
959,800
SMCI icon
19
Super Micro Computer
SMCI
$19.5B
$8.72M 0.78%
2,383,660
BBL
20
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$8.31M 0.74%
+163,983
New +$9.86M
SKIL.WS
21
DELISTED
Skillsoft Corp. Warrants, each whole warrant is exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SKIL.WS
$8.07M 0.72%
+690,706
New +$1.35M
HCAR
22
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$7.83M 0.7%
802,640
AGAC.WS
23
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$7.78M 0.7%
800,829
+87,676
+12% +$48K
MRLN
24
DELISTED
Marlin Business Services Corp
MRLN
$6.92M 0.62%
311,453
+108,963
+54% +$2.44M
PUCKW
25
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$6.68M 0.6%
687,658
-12,342
-2% -$7.78K

Similar funds

Mangrove Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Mangrove Partners held 462 positions worth $1.12B, up 15% from $971M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Mangrove Partners's Q3 2021 filing shows 136 new, 57 increased, 41 reduced and 111 closed positions. Its largest new stake was Biogen: 45,872 shares worth $13M. The largest sale was Macquarie Infrastructure Holdings, LLC, an estimated $32.2M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 37% a quarter earlier, followed by Healthcare and Technology.

  • Mangrove Partners's largest Q3 2021 buy was Biogen: 45,872 shares worth $13M.
  • Mangrove Partners added most to Travere Therapeutics in Q3 2021, an estimated $6.57M increase.
  • Mangrove Partners's biggest Q3 2021 reduction was Pershing Square Tontine Holdings, Ltd., cutting an estimated $12.8M.
  • Mangrove Partners fully exited Macquarie Infrastructure Holdings, LLC in Q3 2021, selling an estimated $32.2M.
  • Mangrove Partners's ten largest holdings make up 17% of its $1.12B portfolio in Q3 2021.
  • Mangrove Partners opened 136 new positions and closed 111 in Q3 2021.
  • Mangrove Partners's portfolio value rose 15% quarter-over-quarter to $1.12B.

Based on Mangrove Partners's 13F filing for Q3 2021, filed 15 Nov 2021.